The oral pharmaceutical formulation contains a core and a drug coating layer.
所述口服药物制剂含有核和药物涂层。
This invention relates to a stable pharmaceutical formulation containing olanzapine.
本发明涉及一种稳定的包含奥氮平的药物制剂。
The oral pharmaceutical formulation can optionally contain a protective layer, such as polyethylene glycol 20,000.
所述口服药物制剂可以任选地含有保护层,诸如聚乙二醇20,000。
The invention relates to a pharmaceutical formulation which is characterised by delayed release of the active ingredient.
本发明涉及一种药物制剂,其特征在于其可延迟活性成分的释放。
Objective To screen out an optimum pharmaceutical formulation of intra-gastric floating sustained-release tablet of Zuojin Pills (IFTZ).
目的优选左金丸胃内漂浮缓释片的制剂配方。
Objective To screen out an optimum pharmaceutical formulation of intra-gastric floating sustained-release tablet of Zuojin Pills (IFTZ).
目的优选左金丸胃内漂浮缓释片的制剂配方。
应用推荐